These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
486 related items for PubMed ID: 11980330
1. [Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients]. Ombandza-Moussa E, Schlegel L, Vekhoff A, Gerbal R, Marie JP, Bouvet A. Pathol Biol (Paris); 2002 Apr; 50(3):169-77. PubMed ID: 11980330 [Abstract] [Full Text] [Related]
2. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. Wisplinghoff H, Reinert RR, Cornely O, Seifert H. J Clin Microbiol; 1999 Jun; 37(6):1876-80. PubMed ID: 10325340 [Abstract] [Full Text] [Related]
3. Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat. Wudhikarn K, Gingrich RD, de Magalhaes Silverman M. Ann Hematol; 2013 Jan; 92(1):129-31. PubMed ID: 22869090 [No Abstract] [Full Text] [Related]
4. Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality. Fernández Guerrero ML, Ramos JM, Marrero J, Cuenca M, Fernández Roblas R, de Górgolas M. Int J Infect Dis; 2003 Mar; 7(1):46-52. PubMed ID: 12718810 [Abstract] [Full Text] [Related]
5. Streptococcal and enterococcal bacteremia in patients with cancer. Awada A, van der Auwera P, Meunier F, Daneau D, Klastersky J. Clin Infect Dis; 1992 Jul; 15(1):33-48. PubMed ID: 1617072 [Abstract] [Full Text] [Related]
6. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections. Kramer TS, Remschmidt C, Werner S, Behnke M, Schwab F, Werner G, Gastmeier P, Leistner R. Antimicrob Resist Infect Control; 2018 Jul; 7():133. PubMed ID: 30459945 [Abstract] [Full Text] [Related]
7. Antibiotic susceptibility of streptococci isolated from blood from neutropenic patients. Piérard D, de Meyer A, Lauwers S. Pathol Biol (Paris); 1994 May; 42(5):471-4. PubMed ID: 7824316 [Abstract] [Full Text] [Related]
8. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients]. Marron A, Carratalà J, Ayats J, Fernández de Sevilla A, Domínguez MA, Liñares J, Gudiol F. Med Clin (Barc); 1998 Dec 12; 111(20):761-4. PubMed ID: 9922964 [Abstract] [Full Text] [Related]
9. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. Chou YY, Lin TY, Lin JC, Wang NC, Peng MY, Chang FY. J Microbiol Immunol Infect; 2008 Apr 12; 41(2):124-9. PubMed ID: 18473099 [Abstract] [Full Text] [Related]
10. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002). Kumashi P, Girgawy E, Tarrand JJ, Rolston KV, Raad II, Safdar A. Medicine (Baltimore); 2005 Sep 12; 84(5):303-312. PubMed ID: 16148730 [Abstract] [Full Text] [Related]
11. Enterococcal Bacteremia in Children With Malignancies and Following Hematopoietic Stem Cell Transplantation: A 15-Year Single-Center Experience. Friedman G, Stepensky P, Abu Ahmad W, Masarwa R, Temper V, Oster Y, Amit S, Averbuch D. Pediatr Infect Dis J; 2020 Apr 12; 39(4):318-324. PubMed ID: 31990889 [Abstract] [Full Text] [Related]
12. [Analysis of 117 episodes of enterococcal bacteremia: Study of epidemiology, microbiology and antimicrobial susceptibility]. Manassero NC, Navarro M, Rocchi M, di Bella H, Gasparotto AM, Ocaña Carrizo AV, Novillo F, Furiasse D, Monterisi A. Rev Argent Microbiol; 2016 Apr 12; 48(4):298-302. PubMed ID: 27567523 [Abstract] [Full Text] [Related]
13. Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010. Mendes RE, Woosley LN, Farrell DJ, Sader HS, Jones RN. Antimicrob Agents Chemother; 2012 Mar 12; 56(3):1639-42. PubMed ID: 22183169 [Abstract] [Full Text] [Related]
14. Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens. Severina E, Severin A, Tomasz A. J Antimicrob Chemother; 1998 Mar 12; 41(3):341-7. PubMed ID: 9578160 [Abstract] [Full Text] [Related]
15. Impact of Enterococcal Bacteremia in Liver Transplant Recipients. Kim YJ, Jun YH, Choi HJ, You YK, Kim DG, Choi JY, Yoon SK, Kim SI. Transplant Proc; 2019 Oct 12; 51(8):2766-2770. PubMed ID: 31493916 [Abstract] [Full Text] [Related]
16. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Forrest GN, Roghmann MC, Toombs LS, Johnson JK, Weekes E, Lincalis DP, Venezia RA. Antimicrob Agents Chemother; 2008 Oct 12; 52(10):3558-63. PubMed ID: 18663022 [Abstract] [Full Text] [Related]
17. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients. Huang WT, Chang LY, Hsueh PR, Lu CY, Shao PL, Huang FY, Lee PI, Chen CM, Lee CY, Huang LM. J Microbiol Immunol Infect; 2007 Aug 12; 40(4):349-54. PubMed ID: 17712470 [Abstract] [Full Text] [Related]
19. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I. Infect Control Hosp Epidemiol; 2007 Sep 08; 28(9):1054-9. PubMed ID: 17932826 [Abstract] [Full Text] [Related]
20. Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? Olaison L, Schadewitz K, Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis. Clin Infect Dis; 2002 Jan 15; 34(2):159-66. PubMed ID: 11740702 [Abstract] [Full Text] [Related] Page: [Next] [New Search]